白云山(00874)上涨5.06%,报19.52元/股

金融界
27 Sep 2024

9月27日,白云山(00874)盘中上涨5.06%,截至11:31,报19.52元/股,成交2748.03万元。

广州白云山医药集团股份有限公司主要从事中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研究开发、制造与销售,以及西药、中药和医疗器械的批发、零售和进出口业务。同时,公司还涉足大健康产品的研发、生产与销售,以及医疗服务、健康管理、养生养老等健康产业投资。

截至2024年中报,白云山营业总收入410.43亿元、净利润25.5亿元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10